| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Berger Mark Stanley serves as a Chief Medical Officer at GNPX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $147K at current prices.
The biggest single holding is GNPX (~$129K) as Chief Medical Officer.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2017 | ATNM Actinium Pharmaceuticals, Inc. | Chief Medical Officer | Buy | 5,000 | $1.11 | $5,550.00 | New |